Decisions Home

Germany EPA and DHA Market Insight

Published: 02 July 2026   |   Report Format: Electronic (PDF)   |   Author: Govind and Krishna

The Germany EPA and DHA market is expected to witness robust growth at a CAGR of 5.92% owing to rising health awareness, increasing functional food preference, and strong supplement demand.

Germany EPA and DHA Market Insights Forecasts to 2035

  • The Germany EPA and DHA Market Size Was Estimated at USD 320.4 Million in 2025.
  • The Market Size is Expected to Grow at a CAGR of around 5.92% from 2025 to 2035.
  • The Germany EPA and DHA Market Size is Expected to rise around USD 565.8 Million by 2035.

 

Notable Insights for the Germany EPA and DHA Market

  • As of 2025, almost 53% of the German market share for EPA and DHA relates to omega-3 dietary supplement demand, driven by aging populations focusing on cardiovascular health daily.
  • The largest share of the market in 2025, almost 58%, is in infant formula and fortification, likely growing due to parents prioritizing enhanced cognitive development and early-life nutritional support.
  • In the year ended 30 September 2025, BASF SE will have an expected gross revenue of $75.2 billion from a growing market for specialized nutritional ingredients and advanced lipid technologies.
  • Expectations continue to rise for new trends in marine-alternative sources, along with new systems to deliver EPA/DHA that maintain up to 48% higher bioavailability and reduce 29% in oxidation.

Download the eBook (ToC)

We value your privacy.

Research Methodologies Used to Analyze the Germany EPA and DHA Market

The German EPA and DHA market has been analyzed using a mixture of both primary sources and secondary data sources. To produce precise evaluations of the EPA and DHA market and predictions about the future development of this sector, other methodologies have also been employed. The primary research included interviews with ingredient manufacturers, supplement processors, healthcare distributors, nutritionists, and retail pharmacy chains to gain insight into consumer buying trends; technological developments; and competitive landscape within the lipid industry. Secondary research included reviewing corporate and government publications, scientific journals related to nutritional science, consumer health studies, import/export statistics, and industry associations as they relate to the omega-3 and marine-oil industries.

 

Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making

What is Decisions Advisors Research?

Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany EPA and DHA Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Companies in Germany EPA and DHA Market

 

Recent Developments:

 

Market Segmentation:

Germany EPA and DHA Market, By Product Type

Germany EPA and DHA Market, By Technology

Germany EPA and DHA Market, By Nature of Use

 

Expert Views:

Due to rising demand for using premium omega-3 ingredients, growing numbers of aging demographics, and developing interest in using advanced clean label nutritional products with high stability, the EPA and DHA category will also see continued growth from technological innovations that improve extraction efficiencies, including the introduction of new molecular distillation technologies; new enzymatic concentration equipment; and new lipid stabilization systems. These new technologies will facilitate production efficiencies as well as create added demand for EPA and DHA across several key consumer health applications.


Author: Govind and Krishna By Decisions Advisors and Consulting